Logo image of VEEV

VEEVA SYSTEMS INC-CLASS A (VEEV) Stock Fundamental Analysis

NYSE:VEEV - New York Stock Exchange, Inc. - US9224751084 - Common Stock - Currency: USD

215.95  -4.71 (-2.13%)

After market: 217 +1.05 (+0.49%)

Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to VEEV. VEEV was compared to 37 industry peers in the Health Care Technology industry. Both the health and profitability get an excellent rating, making VEEV a very profitable company, without any liquidiy or solvency issues. VEEV is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings would make VEEV suitable for growth and quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

VEEV had positive earnings in the past year.
VEEV had a positive operating cash flow in the past year.
VEEV had positive earnings in each of the past 5 years.
Each year in the past 5 years VEEV had a positive operating cash flow.
VEEV Yearly Net Income VS EBIT VS OCF VS FCFVEEV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

1.2 Ratios

VEEV has a Return On Assets of 9.73%. This is amongst the best in the industry. VEEV outperforms 94.59% of its industry peers.
The Return On Equity of VEEV (12.24%) is better than 94.59% of its industry peers.
With an excellent Return On Invested Capital value of 9.79%, VEEV belongs to the best of the industry, outperforming 91.89% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for VEEV is in line with the industry average of 7.17%.
The 3 year average ROIC (9.16%) for VEEV is below the current ROIC(9.79%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.73%
ROE 12.24%
ROIC 9.79%
ROA(3y)9.59%
ROA(5y)10.49%
ROE(3y)12.23%
ROE(5y)13.63%
ROIC(3y)9.16%
ROIC(5y)11.04%
VEEV Yearly ROA, ROE, ROICVEEV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

VEEV has a Profit Margin of 26.00%. This is amongst the best in the industry. VEEV outperforms 94.59% of its industry peers.
VEEV's Profit Margin has been stable in the last couple of years.
With an excellent Operating Margin value of 25.36%, VEEV belongs to the best of the industry, outperforming 97.30% of the companies in the same industry.
VEEV's Operating Margin has been stable in the last couple of years.
VEEV has a Gross Margin of 74.53%. This is amongst the best in the industry. VEEV outperforms 83.78% of its industry peers.
VEEV's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 25.36%
PM (TTM) 26%
GM 74.53%
OM growth 3Y-2.45%
OM growth 5Y-0.44%
PM growth 3Y4.03%
PM growth 5Y-0.95%
GM growth 3Y0.79%
GM growth 5Y0.55%
VEEV Yearly Profit, Operating, Gross MarginsVEEV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so VEEV is destroying value.
The number of shares outstanding for VEEV has been increased compared to 1 year ago.
The number of shares outstanding for VEEV has been increased compared to 5 years ago.
There is no outstanding debt for VEEV. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
VEEV Yearly Shares OutstandingVEEV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
VEEV Yearly Total Debt VS Total AssetsVEEV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

VEEV has an Altman-Z score of 16.13. This indicates that VEEV is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 16.13, VEEV belongs to the best of the industry, outperforming 89.19% of the companies in the same industry.
There is no outstanding debt for VEEV. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 16.13
ROIC/WACC0.93
WACC10.5%
VEEV Yearly LT Debt VS Equity VS FCFVEEV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.3 Liquidity

A Current Ratio of 4.51 indicates that VEEV has no problem at all paying its short term obligations.
VEEV's Current ratio of 4.51 is amongst the best of the industry. VEEV outperforms 91.89% of its industry peers.
A Quick Ratio of 4.51 indicates that VEEV has no problem at all paying its short term obligations.
VEEV has a better Quick ratio (4.51) than 91.89% of its industry peers.
Industry RankSector Rank
Current Ratio 4.51
Quick Ratio 4.51
VEEV Yearly Current Assets VS Current LiabilitesVEEV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

7

3. Growth

3.1 Past

VEEV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.57%, which is quite impressive.
VEEV shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 24.72% yearly.
VEEV shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.20%.
The Revenue has been growing by 19.99% on average over the past years. This is quite good.
EPS 1Y (TTM)36.57%
EPS 3Y21.12%
EPS 5Y24.72%
EPS Q2Q%26.09%
Revenue 1Y (TTM)16.2%
Revenue growth 3Y14.06%
Revenue growth 5Y19.99%
Sales Q2Q%14.31%

3.2 Future

Based on estimates for the next years, VEEV will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.05% on average per year.
The Revenue is expected to grow by 13.21% on average over the next years. This is quite good.
EPS Next Y13.24%
EPS Next 2Y11.67%
EPS Next 3Y11.88%
EPS Next 5Y14.05%
Revenue Next Year11.95%
Revenue Next 2Y11.84%
Revenue Next 3Y12.25%
Revenue Next 5Y13.21%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
VEEV Yearly Revenue VS EstimatesVEEV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
VEEV Yearly EPS VS EstimatesVEEV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10 15

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 32.67, the valuation of VEEV can be described as expensive.
83.78% of the companies in the same industry are more expensive than VEEV, based on the Price/Earnings ratio.
VEEV is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 28.29, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 28.85 indicates a quite expensive valuation of VEEV.
Based on the Price/Forward Earnings ratio, VEEV is valued a bit cheaper than the industry average as 78.38% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of VEEV to the average of the S&P500 Index (21.08), we can say VEEV is valued slightly more expensively.
Industry RankSector Rank
PE 32.67
Fwd PE 28.85
VEEV Price Earnings VS Forward Price EarningsVEEV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

VEEV's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. VEEV is cheaper than 72.97% of the companies in the same industry.
VEEV's Price/Free Cash Flow ratio is rather cheap when compared to the industry. VEEV is cheaper than 81.08% of the companies in the same industry.
Industry RankSector Rank
P/FCF 32.85
EV/EBITDA 35.27
VEEV Per share dataVEEV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates VEEV does not grow enough to justify the current Price/Earnings ratio.
VEEV has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.47
PEG (5Y)1.32
EPS Next 2Y11.67%
EPS Next 3Y11.88%

0

5. Dividend

5.1 Amount

VEEV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

VEEVA SYSTEMS INC-CLASS A

NYSE:VEEV (4/17/2025, 8:04:00 PM)

After market: 217 +1.05 (+0.49%)

215.95

-4.71 (-2.13%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)03-05 2025-03-05/amc
Earnings (Next)05-28 2025-05-28/amc
Inst Owners84.77%
Inst Owner Change0.01%
Ins Owners8.83%
Ins Owner Change0.07%
Market Cap35.14B
Analysts77.37
Price Target272.21 (26.05%)
Short Float %2.71%
Short Ratio3.34
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.29%
Min EPS beat(2)7.97%
Max EPS beat(2)8.61%
EPS beat(4)4
Avg EPS beat(4)5.82%
Min EPS beat(4)3.17%
Max EPS beat(4)8.61%
EPS beat(8)8
Avg EPS beat(8)5.77%
EPS beat(12)11
Avg EPS beat(12)5.29%
EPS beat(16)15
Avg EPS beat(16)5.79%
Revenue beat(2)1
Avg Revenue beat(2)0.34%
Min Revenue beat(2)-0.41%
Max Revenue beat(2)1.09%
Revenue beat(4)1
Avg Revenue beat(4)-0.21%
Min Revenue beat(4)-0.82%
Max Revenue beat(4)1.09%
Revenue beat(8)2
Avg Revenue beat(8)-0.57%
Revenue beat(12)2
Avg Revenue beat(12)-0.57%
Revenue beat(16)4
Avg Revenue beat(16)-0.26%
PT rev (1m)0.83%
PT rev (3m)-0.45%
EPS NQ rev (1m)0.34%
EPS NQ rev (3m)7.31%
EPS NY rev (1m)6.21%
EPS NY rev (3m)6.2%
Revenue NQ rev (1m)-0.08%
Revenue NQ rev (3m)-0.28%
Revenue NY rev (1m)-0.19%
Revenue NY rev (3m)-0.19%
Valuation
Industry RankSector Rank
PE 32.67
Fwd PE 28.85
P/S 12.79
P/FCF 32.85
P/OCF 32.23
P/B 6.02
P/tB 6.57
EV/EBITDA 35.27
EPS(TTM)6.61
EY3.06%
EPS(NY)7.49
Fwd EY3.47%
FCF(TTM)6.57
FCFY3.04%
OCF(TTM)6.7
OCFY3.1%
SpS16.88
BVpS35.85
TBVpS32.87
PEG (NY)2.47
PEG (5Y)1.32
Profitability
Industry RankSector Rank
ROA 9.73%
ROE 12.24%
ROCE 11.72%
ROIC 9.79%
ROICexc 73.54%
ROICexgc 189.64%
OM 25.36%
PM (TTM) 26%
GM 74.53%
FCFM 38.94%
ROA(3y)9.59%
ROA(5y)10.49%
ROE(3y)12.23%
ROE(5y)13.63%
ROIC(3y)9.16%
ROIC(5y)11.04%
ROICexc(3y)59.89%
ROICexc(5y)59.49%
ROICexgc(3y)196.73%
ROICexgc(5y)318.62%
ROCE(3y)10.96%
ROCE(5y)13.22%
ROICexcg growth 3Y-36.21%
ROICexcg growth 5Y-13.57%
ROICexc growth 3Y1.45%
ROICexc growth 5Y14.29%
OM growth 3Y-2.45%
OM growth 5Y-0.44%
PM growth 3Y4.03%
PM growth 5Y-0.95%
GM growth 3Y0.79%
GM growth 5Y0.55%
F-Score7
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 52.1%
Cap/Sales 0.75%
Interest Coverage 250
Cash Conversion 148.14%
Profit Quality 149.76%
Current Ratio 4.51
Quick Ratio 4.51
Altman-Z 16.13
F-Score7
WACC10.5%
ROIC/WACC0.93
Cap/Depr(3y)59.59%
Cap/Depr(5y)52.02%
Cap/Sales(3y)0.83%
Cap/Sales(5y)0.77%
Profit Quality(3y)158.47%
Profit Quality(5y)158.74%
High Growth Momentum
Growth
EPS 1Y (TTM)36.57%
EPS 3Y21.12%
EPS 5Y24.72%
EPS Q2Q%26.09%
EPS Next Y13.24%
EPS Next 2Y11.67%
EPS Next 3Y11.88%
EPS Next 5Y14.05%
Revenue 1Y (TTM)16.2%
Revenue growth 3Y14.06%
Revenue growth 5Y19.99%
Sales Q2Q%14.31%
Revenue Next Year11.95%
Revenue Next 2Y11.84%
Revenue Next 3Y12.25%
Revenue Next 5Y13.21%
EBIT growth 1Y62.24%
EBIT growth 3Y11.27%
EBIT growth 5Y19.47%
EBIT Next Year20.34%
EBIT Next 3Y16.25%
EBIT Next 5Y17.62%
FCF growth 1Y20.83%
FCF growth 3Y12.54%
FCF growth 5Y19.82%
OCF growth 1Y19.61%
OCF growth 3Y12.55%
OCF growth 5Y20.04%